PedAM
Pediatric Disease Annotations & Medicines
| Disease | acute myocardial infarction |
| Phenotype | C0027051|myocardial infarct |
| Sentences | 7 |
| PubMedID- 26161105 | The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with st elevation acute myocardial infarction before primary coronary intervention. |
| PubMedID- 20487120 | Methods: the study included 271 patients from the cardiac arrhythmias and risk stratification after myocardial infarction (carisma) study with an acute myocardial infarction (ami) and left ventricular ejection fraction |
| PubMedID- 20691832 | Predicting chronic left ventricular dysfunction 90 days after st-segment elevation myocardial infarction: an assessment of pexelizumab in acute myocardial infarction (apex-ami) substudy. |
| PubMedID- 24634292 | Association of plasma b-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction. |
| PubMedID- 23364453 | It has been shown that administration of glp-1 at the time of reperfusion was effective in decreasing myocardial infarct size in patients with acute myocardial infarction (8). |
| PubMedID- 21742094 | Cardiogenic shock and heart failure post-percutaneous coronary intervention in st-elevation myocardial infarction: observations from "assessment of pexelizumab in acute myocardial infarction". |
| PubMedID- 24562803 | The seattle post myocardial infarction model (spim): prediction of mortality after acute myocardial infarction with left ventricular dysfunction. |
Page: 1